Trial Details
TERMINATEDBasic Information
| Clinical ID | c1179 |
|---|---|
| Identifier | NCT00355901 |
| Trial Title | An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Visilizumab (Nuvion; HuM291) |
Participant Information
| Sponsor | PDL BioPharma, Inc. |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-09-06 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2025-11-12 |